WCN26-6488 Efficacy and Safety of Intraoperative Fasudil Hydrochloride Administration on Early Arteriovenous Fistula Creation: A Propensity Score-Matched Pilot Study

Read full text Summarise with VIRAT
Authors: Motonobu Nakamura, Daisuke Yamada, Nobuhiko Satoh, Mariko Kawamura, Kenji Yoda, Ryo Mastuura, Kenichi Hashimoto, Masaomi Nangaku, Haruki Kume
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Vascular access (VA), optimally a subcutaneous arteriovenous fistula (AVF), is essential for hemodialysis. However, intraoperative vascular spasm during AVF creation can lead to early occlusion. While traditional agents like heparin or papaverine are sometimes administered, clear evidence supporting their practice is lacking. Fasudil hydrochloride, a Rho kinase inhibitor, effectively prevents arterial spasm in other vascular procedures, but its efficacy and safety for vasospasm prevention during the complex arterial-venous anastomosis of AVF creation remain unproven.

Fields of Study & Subjects

Central Venous Catheters and Hemodialysis Vascular Procedures and Complications Renal and Vascular Pathologies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105298–105298
Publication date
25 March 2026
Language
EN